Schwegman, Lundberg & Woessner - Intellectual Property Attorneys


Search The Site
Our Firm
Attorneys
Join Us - Life at SLWK
IP Resource Center
Education/Training
What's New
FAQs
Media/Press
Contact Us
Client Log-In
Ranked First In Patent Quality - Learn More
Attorneys - Attorney Profile

Attorneys - Alphabetical Listing

Attorneys By Practice Area

 Content page upper right links


West Legal Directory Profile - Firmsite Warren D. Woessner 
Minneapolis, Minnesota
Founding Shareholder
phone (612) 373-6903
fax (612) 339-3061
email wwoessner@slwip.com

Warren D. Woessner is a registered patent attorney and a founding shareholder of Schwegman, Lundberg & Woessner. His practice focuses on chemical patent law, including biotechnology, pharmaceuticals, vaccines, medical treatments, diagnostics, and biofuels and agricultural chemistry, including related opinion and licensing matters. Warren received his B.A. in chemistry (1966) from Cornell University, his Ph.D. (organic chemistry, 1971) and his law degree (J.D., cum laude, 1981) from the University of Wisconsin - Madison. From 1972-1978 he worked for Miles Laboratories in new drug research. Warren was an associate attorney at Kenyon & Kenyon from 1981-1984, and then joined Merchant & Gould in Minneapolis. He founded their chemical practice group and became a partner in 1989. Warren also co-founded the Biotechnology Committee of the Minnesota Intellectual Property Law Association. He has published and spoken widely on legal topics, was the 1993-1995 chair of the Chemical Practice Committee of the American Intellectual Property Law Association, chaired the Biotechnology Committee (2003-2005) and is currently a member of the Amicus Committee. He co-authored the AIPLA amicus briefs to the Federal Circuit and the Supreme Court in J.E.M. Ag Supply v. Pioneer HiBred. Warren is a member of the Board of Advisers of "Patent Strategy & Management" (American Lawyer Media Inc.)  He is also a Certified Licensing Professional - LES.

Areas of Practice:
Biotechnology
Chemical
Material Science
Medical Technology/Devices
Pharmaceutical
Veterinary Medicine
Nanotechnology
Biofuels/Biomass Conversion
Bar Admissions:
Minnesota, 1984
New York, 1982
U.S. Court of Appeals Federal Circuit, 1986
U.S. Patent and Trademark Office, 1981
Education:
University of Wisconsin, Madison, WI , 1981
J.D.
Honors: Cum Laude
Law Review: Wisconsin Law Review, 1980 - 1981


University of Wisconsin, Madison, Wisconsin, 1971
Ph.D.
Major:  Organic Chemistry


Cornell University, Ithaca, New York, 1966
B.A.
Major:  Chemistry


Published Works:
"Do-Over!' - The Federal Circuit Takes a Second Look at Enzo,", J. Patent and Trademark Office Society, 85, 275, 2003


"Let's Get Physical" - Invited Open Peer Commentary on R. Eisenburg," How Can You Patent Genes?", AM.J. Bioethics, 2, 21, 2002


"Ruling Blunts Enzo's Attack on Biotechnology.", Patent Strategy & Management, 3, 1, 2002


"The Evolution of Patents on Life--Transgenic Animals, Clones and Stem Cells", J. Patent and Trademark Office Society, 83, 830, 2001


"New PTO Guidelines Raise Standards for Patenting Biological Materials", Patent Strategy & Management, 11, April, 2001


"Supreme Court Should Confirm Patent Rights for Biotech Plants", Legal Opinion Letter, Washington Legal Foundation, 11, No. 11, July 27, 2001


"The Evolution of Patents on Life--Transgenic Animals, Clones and Stem Cells", J. Patent and Trademark Office Society, 83, 830, 2001


"Point of View--Guidelines for Patenting Biologicals", Genetic Engineering, 20, 6, 2000


Representative Cases:
Aesgen, Inc., (U.S. Patent No. 7,041,651) (CELLULAR UPTAKE OF BIOACTIVE AGENTS  )
Orphan Medical, Inc., (U.S. Patent No. 7,015,200) (GAMMA-HYDROXYBUTYRATE COMPOSITIONS CONTAINING CARBOHYDRATE, LIPID OR A  )
Aesgan, Inc., (U.S. Patent No. 6,734,170) (CELLULAR UPTAKE OF BIOACTIVE AGENTS  )
NeoRx Corporation, (U.S. Patent No. 6,767,531) (HIGH DOSE RADIONUCLIDE COMPLEXES FOR BONE MARROW SUPPRESSION  )
NeoRx Corporation, (U.S. Patent No. 7,070,759) (HIGH DOSE RADIONUCLIDE COMPLEXES FOR BONE MARROW SUPPRESSION  )
Indiana University Research and Technology Corporation, (U.S. Patent No. 6,890,946) (USE OF PARTHENOLIDE TO INHIBIT CANCER  )
Research Corporation Technologies, Inc., (U.S. Patent No. 7,011,831) (RECOMBINANT [alpha symbol]-GALACTOSIDASE A THERAPY FOR FABRY DISEASE  )
Professional Associations and Memberships:
Minnesota Intellectual Property Law Association
Co-founder, Biotechnology Committee


American Intellectual Property Law Association, 1993 - 1995
Chair, Chemical Practice Committee


American Intellectual Property Law Association, 2003 - Present
Chair, Biotechnology Committee


PTO Biotechnology Customer Partnership
ABA Representative


"Patent Strategy & Management" (American Lawyer Media Inc.)
Member, Board of Advisers


Past Employment Positions:
Miles Laboratories, 1972 - 1978


Kenyon & Kenyon, Associate Attorney, 1981 - 1984


Merchant & Gould, Founder, Chemical Practice Group, Partner, 1989


 



Add contact information to your vCard compatible address book. VCard


Related Information

Representative Patents

SLWK Publications



Printable Format
SLW has obtained over 3,000 patents in its first ten years.



Our Firm   Attorneys   Join Us - Life at SLW   IP Resource Center   Education/Training   What's New   FAQs   Media/Press   Contact Us   Client Log-In   Home   Site Map

© 2008 Schwegman, Lundberg & Woessner, P.A. All Rights Reserved.